‘New York Times’ Opinion Piece Argues for Stricter FDA Regulation of Medical Devices
In a recent “New York Times” Op-Ed piece, The Editorial Board (representing the opinions of the board, its editor, and the publisher) argues that the US Food and Drug Administration (FDA) may be failing to adequately monitor the products they approve, after several medical devices have caused health problems in patients.
Read More